| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/12/2013 | CN101574373B Toad venom alcohol plastid and preparation method thereof |
| 06/12/2013 | CN101569589B Clindamycin phosphate for injection and preparation method thereof |
| 06/12/2013 | CN101554368B Tetrodotoxin composition formulation stable at room temperature and used for injection |
| 06/12/2013 | CN101489641B Use of tannins in filters |
| 06/12/2013 | CN101472577B Infusion preparation for dialysis patient |
| 06/12/2013 | CN101421303B Improved protofibril selective antibodies and the use thereof |
| 06/12/2013 | CN101401799B Method for preparing farina microcapsule medicament |
| 06/12/2013 | CN101380379B Total flavone in leaves of Murraya paniculata (L.) Jack and preparation method and use thereof |
| 06/12/2013 | CN101361757B Combination containing brown alga polysaccharide sulfuric ester and propolis and use thereof |
| 06/12/2013 | CN101325946B Hair treatment compositions |
| 06/12/2013 | CN101190248B Long chain fatty milk in camelina sativa oil orally-administered or injection preparations |
| 06/12/2013 | CN101155594B Cream loaded with shellfish firing product powder and process for producing the same |
| 06/11/2013 | US8461226 Contact lens |
| 06/11/2013 | US8461211 Use for budesonide and formoterol |
| 06/11/2013 | US8461203 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/11/2013 | US8461187 Multiple PPI dosage form |
| 06/11/2013 | US8461155 Binding to LRP5 or LRP6 receptor; promoting growth with DAN family bone morphogenetic protein antagonist |
| 06/11/2013 | US8461136 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 06/11/2013 | US8461116 Liquid composition of factor VII polypeptides |
| 06/11/2013 | US8461105 Polymer-based sustained release device |
| 06/11/2013 | US8461081 Herbicidal compositions containing glyphosate |
| 06/11/2013 | US8460712 Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate |
| 06/11/2013 | US8460711 Poly(citric acid) functionalized carbon nanotube drug delivery system |
| 06/11/2013 | US8460710 Antibiotic product, use and formulation thereof |
| 06/11/2013 | US8460709 Pharmaceutical microparticles |
| 06/11/2013 | US8460708 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 06/11/2013 | US8460707 Stabilised prostaglandin composition |
| 06/11/2013 | US8460706 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 06/11/2013 | US8460705 Threo-DOPS controlled release formulation |
| 06/11/2013 | US8460704 Extended release formulation of nevirapine |
| 06/11/2013 | US8460702 Pharmaceutical compositions |
| 06/11/2013 | US8460701 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 06/11/2013 | US8460700 First aid formulations of turmeric powder lavender essential oil and glycerin for dressing wounds |
| 06/11/2013 | US8460699 Clay-based hemostatic agents and devices for the delivery thereof |
| 06/11/2013 | US8460694 Solvent/polymer solutions as suspension vehicles |
| 06/11/2013 | US8460692 Alginate-based nanofibers and related scaffolds |
| 06/11/2013 | US8460686 Bioactive bone graft substitute |
| 06/11/2013 | US8460685 Method of improving the osteoinductivity of calcium phosphate |
| 06/11/2013 | US8460663 Stabilized liquid anti-RSV antibody formulations |
| 06/11/2013 | US8460644 Synergistic mixed poloxamer systems for the solubilisation of drugs |
| 06/11/2013 | US8460641 Microemulsion process and composition |
| 06/11/2013 | US8459046 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product |
| 06/11/2013 | CA2777015C Film coating agent for solid preparation, and solid preparation using same |
| 06/11/2013 | CA2690488C Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
| 06/11/2013 | CA2682678C Fluid delivery assembly |
| 06/11/2013 | CA2559161C Irna agents targeting vegf |
| 06/11/2013 | CA2531721C Dual drug dosage forms with improved separation of drugs |
| 06/11/2013 | CA2519418C New injectable formulations containing progesterone |
| 06/11/2013 | CA2491484C Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 06/11/2013 | CA2437064C Storage-stable, liquid fibrinogen formulation |
| 06/11/2013 | CA2427334C Methods and compositions for the treatment of diseases of the eye |
| 06/11/2013 | CA2406277C Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 06/11/2013 | CA2363705C Devices and methods for pain management |
| 06/07/2013 | CA2761212A1 Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of it manufacturing |
| 06/06/2013 | WO2013082590A1 Peg based hydrogel for peripheral nerve injury applications and compositions and method of use of synthetic hydrogel sealants |
| 06/06/2013 | WO2013082573A1 Acamprosate formulations, methods of using the same, and combinations comprising the same |
| 06/06/2013 | WO2013082565A1 Therapies for disorders of the cornea and conjunctiva |
| 06/06/2013 | WO2013082529A1 Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery |
| 06/06/2013 | WO2013082504A1 Bioavailability enhancement delivery composition |
| 06/06/2013 | WO2013082503A1 Peptide particle formulation |
| 06/06/2013 | WO2013082470A1 Amphipathic lipid-based sustained release compositions |
| 06/06/2013 | WO2013082458A1 Reperfusion protection solution and uses thereof |
| 06/06/2013 | WO2013082449A2 Treatment of b cell lymphomas |
| 06/06/2013 | WO2013082418A1 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same |
| 06/06/2013 | WO2013082344A1 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use |
| 06/06/2013 | WO2013082340A1 Method of neutralizing an aerosol containing a compound of interest dissolved in a low ph solution |
| 06/06/2013 | WO2013082111A2 Geometrically engineered particles and methods for modulating macrophage or immune responses |
| 06/06/2013 | WO2013082003A1 Compositions and methods for treating hepatitis c virus |
| 06/06/2013 | WO2013081928A2 Method and composition for hyperthermally treating cells |
| 06/06/2013 | WO2013081720A1 Aptamer bioconjugate drug delivery device |
| 06/06/2013 | WO2013081567A1 Effervescent antipsychotic formulations |
| 06/06/2013 | WO2013081566A1 A formulation comprising benzimidazole |
| 06/06/2013 | WO2013081563A2 Stable tablet formulations |
| 06/06/2013 | WO2013081562A1 Oral formulations comprising ebastine |
| 06/06/2013 | WO2013081226A1 Novel phytospingosine derivatives and method for preparing same |
| 06/06/2013 | WO2013081217A1 Surface-modified ultraviolet blocking powder and ultraviolet blocking composition including same |
| 06/06/2013 | WO2013081177A1 Dry coated tablet |
| 06/06/2013 | WO2013081120A1 Lecithin-organogel-forming agent |
| 06/06/2013 | WO2013081102A1 Ropinirole-containing adhesive patch |
| 06/06/2013 | WO2013081044A1 Tablet containing 1-cyclopropyl-8-(difluoromethoxy)-7-[(1r)-1-methyl-2, 3-dihydro-1h-isoindole-5-yl]-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid methanesulfonic acid hydrate |
| 06/06/2013 | WO2013081014A1 Adhesive skin patch |
| 06/06/2013 | WO2013080271A1 Analgesic |
| 06/06/2013 | WO2013080225A2 Novel parenteral controlled release formulations of nsaid's |
| 06/06/2013 | WO2013080205A1 Jojoba extract useful in improving skin barrier functions |
| 06/06/2013 | WO2013080148A1 A process for the preparation of solid dispersion of lopinavir and ritonavir |
| 06/06/2013 | WO2013080028A1 Composition based on ubidecarenone |
| 06/06/2013 | WO2013079975A1 Coated condom |
| 06/06/2013 | WO2013079605A2 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
| 06/06/2013 | WO2013079604A1 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
| 06/06/2013 | WO2013079386A1 Transdermal therapeutic system for administering fentanyl or an analogue thereof |
| 06/06/2013 | WO2013079001A1 Method and device for physically targeting location of magnetic drug using permanent magnets |
| 06/06/2013 | WO2013078998A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine |
| 06/06/2013 | WO2013078973A1 Large particle diameter dasatinib and preparation and use thereof |
| 06/06/2013 | WO2013078754A1 Promoting hair growth solution containing chlorine dioxide， preparation method and use method thereof |
| 06/06/2013 | WO2013078659A1 Natural ingredients that improve blood vessel elasticity |
| 06/06/2013 | WO2013078608A1 Donepezil pamoate and methods of making and using the same |
| 06/06/2013 | WO2013029160A3 Patch for transdermal delivery of erectogenic drug and tactile stimulation |
| 06/06/2013 | WO2013019733A3 Methods, compositions and kits for therapeutic treatment with wet spun microstructures |
| 06/06/2013 | WO2013019372A9 Thermally-conductive, metal-based bandages to aid in medical healing and methods of use |
| 06/06/2013 | WO2013014654A4 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis |